Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DBTI39
|
|||
| Drug Name |
YH010
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Aggressive cancer [ICD-11: 2A00-2F9Z; ICD-10: R45.6; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Biocytogen
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Interleukine 12 (IL-12) | Target Info | . | [1] |
| Programmed cell death 1 ligand 1 (PD-L1) | Target Info | . | [1] | |
| KEGG Pathway | Cell adhesion molecules (CAMs) | |||
| Reactome | PD-1 signaling | |||
| WikiPathways | Costimulation by the CD28 family | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Biocytogen | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.